KASSANDRA GIGLIO: Open Payments
NPI 1629738422 · NEW HARTFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,662 in 90 payments from 23 companies in 2025. Trend: 2023 $1,605 · 2024 $2,616 · 2025 $1,662
Food & beverage: $1,562Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $398 |
| PFIZER INC. | 15 | $239 |
| AstraZeneca Pharmaceuticals LP | 9 | $147 |
| Lilly USA, LLC | 8 | $124 |
| Incyte Corporation | 1 | $100 |
| Lundbeck LLC | 5 | $93 |
| Braeburn Inc. | 4 | $77 |
| Amgen Inc. | 4 | $61 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $52 |
| GlaxoSmithKline, LLC. | 2 | $42 |
Products named: VRAYLAR, NURTEC ODT, MOUNJARO, ELIQUIS, REXULTI, AIRSUPRA, BRIXADI, QULIPTA.
Industry payments across NY — which companies pay providers there.
